EcoDrugPlus

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSATEG00000021465
Gene Symbol: PSMA4
2 Cross references
199 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSATEG00000024286
Gene Symbol: PSMA5
2 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSATEG00000009669
Gene Symbol: PSMA8
3 Cross references
183 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSATEG00000020768
Gene Symbol: PSMB1
2 Cross references
219 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSATEG00000010999
Gene Symbol: PSMB10
2 Cross references
172 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSATEG00000006643
Gene Symbol: PSMB2
3 Cross references
221 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSATEG00000000850
Gene Symbol: PSMB3
2 Cross references
261 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSATEG00000012083
Gene Symbol: PSMB4
2 Cross references
215 Possible Orthologues:

Proteasome 20s Subunit Beta 5

Ensembl ID : ENSATEG00000008354
Gene Symbol: PSMB5
3 Cross references
223 Possible Orthologues:

Proteasome 20s Subunit Beta 7

Ensembl ID : ENSATEG00000007952
Gene Symbol: PSMB7
3 Cross references
215 Possible Orthologues:

Proteasome 20s Subunit Beta 8a

Ensembl ID : ENSATEG00000020862
Gene Symbol: PSMB8A
3 Cross references
220 Possible Orthologues:

Proteasome 20s Subunit Beta 9a

Ensembl ID : ENSATEG00000020815
Gene Symbol: PSMB9A
3 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).